Dr. David Pearson's Herbal Formula
Natural health product licensed in Canada
- Licence holder
- Ankang Herb Canada Inc.
- NPN or DIN-HM
- 80095215
- Status
- Active licence
- Licence date
- 5 November 2019
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
- Conditions légales
Platycodon grandiflorus (Jacq.) A.DC.: L'étiquetage doit comporter un avertissement déconseillant un usage prolongé, tel que "L'usage prolongé peut irriter l'estomac".
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Dioscorea oppositifolia L.: Les matières premières végétales doivent avoir subi les étapes traditionnelles d'épluchage, de lavage et de traitement thermique. L'absence d'alcaloïdes et de composés cyanogènes doit être démontrée par des bulletins d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Platycodon grandiflorus Source : Platycodon grandiflorus - racine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 120 mg | 24 mg | Not calculated |
| Polygonatum cirrhifolium Source : Rhizome Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 100 mg | 20 mg | Not calculated |
| Astragalus membranaceus Source : Racine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 100 mg | 20 mg | Not calculated |
| Dioscorea oppositifolia Source : Rhizome Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 100 mg | 20 mg | Not calculated |
Non-medicinal ingredients
Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 3 Capsule | 3 Tous les jours |
Uses authorised in Canada
Traditionally used in Herbal Medicine as supportive therapy for the promotion of healthy glucose levels. Traditionally used in Herbal Medicine to help reduce elevated blood lipid levels (hyperlipidemia). Combination of Traditional Chinese Medicine Ingredients.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If symptoms persist or worsen, or if new symptoms develop, discontinue use and consult a health care practitioner. If you are taking prescription medications, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you have diabetes or have an autoimmune disorder, or have a liver disorder.
- Contre-indications
If you are pregnant or breastfeeding, do not use this product. Do not use this product if you have hypokalemia, high blood pressure, or a kidney or cardiovascular disorder. Do not use this product if you are taking thiazide diuretics, cardiac glycosides, corticosteroids, stimulant laxatives or other medications which may aggravate electrolyte imbalance. According to Traditional Chinese Medicine, do not use this product in cases of exterior excess, qi stagnation, damp obstruction, food stagnation, yin deficiency with heat signs, or skin lesions in their early stages or where there is a heat toxin.
Source
Official Health Canada record, licence 80095215
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.